Compound 911
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccccc2)c1=O
- IUPAC name:
6-methyl-2-phenyl-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-3-one
- InChi:
InChI=1S/C21H14F3N5O/c1-28-19-15(11-25-28)18-16(20(30)29(27-18)14-8-3-2-4-9-14)17(26-19)12-6-5-7-13(10-12)21(22,23)24/h2-11,27H,1H3
- InChiKey:
XZLYIJJVUYWLSG-UHFFFAOYSA-N
External links
20725611 |
19528228 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.70 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 409.12 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 4.99 | |||
TPSA | 63.05 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4947 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4771 | ATX-914 | DB12673 | |
0.4753 | Tepotinib | DB15133 | |
0.4721 | Riociguat | DB08931 | |
0.4654 | Decoglurant | DB11923 | |
0.4634 | MK-0249 | DB11910 | |
0.4564 | Vericiguat | DB15456 | |
0.4520 | Risdiplam | DB15305 | |
0.4434 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4386 | Dilmapimod | DB12140 | |
0.4381 | ABT-288 | DB15192 | |
0.4352 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4346 | 3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB07210 | |
0.4336 | Ravoxertinib | DB15281 | |
0.4326 | Methaqualone | DB04833 |